These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 201940)

  • 21. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 22. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine-4-O-sulfate: a possible precursor of free norepinephrine.
    Buu NT; Kuchel O
    Can J Biochem; 1979 Sep; 57(9):1159-62. PubMed ID: 509357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I
    Endocrinologie; 1978; 16(4):263-8. PubMed ID: 569899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusaric acid-induced elevation of homovanillic acid in the CSF as an index of brain noradrenaline synthesis.
    Elghozi JL; Laude D; Chaouloff F
    Eur J Pharmacol; 1985 Nov; 117(3):363-7. PubMed ID: 4076351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of food intake by a noradrenergic system using clonidine and fusaric acid in the neonatal chick.
    Bungo T; Shimojo M; Masuda Y; Choi YH; Denbow DM; Furuse M
    Brain Res; 1999 May; 826(2):313-6. PubMed ID: 10224312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitation of brain self-stimulation by central administration of norepinephrine.
    Wise CD; Stein L
    Science; 1969 Jan; 163(3864):299-301. PubMed ID: 5762612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased norepinephrine and epinephrine contents in chromaffin tissue of rainbow trout (Oncorhynchus mykiss) exposed to diethyldithiocarbamate and amylxanthate.
    Nilsson GE; Block M
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 98(2-3):391-4. PubMed ID: 1676955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of the Central Noradrenergic System by
    Alsaady I; Tedford E; Alsaad M; Bristow G; Kohli S; Murray M; Reeves M; Vijayabaskar MS; Clapcote SJ; Wastling J; McConkey GA
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510101
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
    Ross SB; Ogren SO
    J Pharm Pharmacol; 1976 Jul; 28(7):590-2. PubMed ID: 8618
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of phenylethanolamine N-methyltransferase and dopamine-beta-hydroxylase inhibition on epinephrine levels in the brain.
    Sauter AM; Lew JY; Baba Y; Goldstein M
    Life Sci; 1977 Jul; 21(2):261-6. PubMed ID: 196153
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory effect of neuropeptide Y (NPY) on the in vitro activity of dopamine-beta-hydroxylase.
    Cheng JT; Chang CL; Tsai CL
    Neurosci Lett; 1992 Feb; 136(1):36-8. PubMed ID: 1635665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of in vivo dopamine- -hydroxylase activity in rat brain.
    Stolk JM
    J Pharmacol Exp Ther; 1973 Aug; 186(2):230-40. PubMed ID: 4719778
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.